Company Information

Company Optima Pharmazeutische GmbH
Pharmaceuticals & Biotechnology
Privately Held
Global Compact Status:
Participant Since
05 May 2014
Letter of Commitment
Next Communication on Progress (COP) due on:
31 July 2024

Communication On Progress

Published On Title Level/Status
16-Jun-2023 2023 Communication on Progress Submitted
05-May-2022 Optima Pharma Sustainability Report Active
07-May-2021 Optima - Sustainability Report 2021 Active
08-May-2020 Optima - Sustainability Report 2020 Active
08-May-2019 Optima - Sustainability Report 2019 Active
08-May-2018 Optima - Sustainability Report 2018 Active
08-May-2017 Optima - Sustainability Report 2017 Active
06-May-2016 Sustainability Report 2015 / UNGC COP Active
05-May-2015 Sustainability Report 2015 / UNGC COP Active

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.